[go: up one dir, main page]

FR3015481B1 - Utilisation de composes de diaminophenothiazinium en tant qu'agents de prevention, reduction ou suppression d'une radiotoxicite - Google Patents

Utilisation de composes de diaminophenothiazinium en tant qu'agents de prevention, reduction ou suppression d'une radiotoxicite

Info

Publication number
FR3015481B1
FR3015481B1 FR1303033A FR1303033A FR3015481B1 FR 3015481 B1 FR3015481 B1 FR 3015481B1 FR 1303033 A FR1303033 A FR 1303033A FR 1303033 A FR1303033 A FR 1303033A FR 3015481 B1 FR3015481 B1 FR 3015481B1
Authority
FR
France
Prior art keywords
radiotoxicity
suppressing
agents
preventing
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1303033A
Other languages
English (en)
Other versions
FR3015481A1 (fr
Inventor
Julien Thourot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Direction General de lArmement DGA
Original Assignee
Delegation Generale pour lArmement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delegation Generale pour lArmement filed Critical Delegation Generale pour lArmement
Priority to FR1303033A priority Critical patent/FR3015481B1/fr
Publication of FR3015481A1 publication Critical patent/FR3015481A1/fr
Application granted granted Critical
Publication of FR3015481B1 publication Critical patent/FR3015481B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1303033A 2013-12-20 2013-12-20 Utilisation de composes de diaminophenothiazinium en tant qu'agents de prevention, reduction ou suppression d'une radiotoxicite Expired - Fee Related FR3015481B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1303033A FR3015481B1 (fr) 2013-12-20 2013-12-20 Utilisation de composes de diaminophenothiazinium en tant qu'agents de prevention, reduction ou suppression d'une radiotoxicite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1303033A FR3015481B1 (fr) 2013-12-20 2013-12-20 Utilisation de composes de diaminophenothiazinium en tant qu'agents de prevention, reduction ou suppression d'une radiotoxicite

Publications (2)

Publication Number Publication Date
FR3015481A1 FR3015481A1 (fr) 2015-06-26
FR3015481B1 true FR3015481B1 (fr) 2016-08-12

Family

ID=50976675

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1303033A Expired - Fee Related FR3015481B1 (fr) 2013-12-20 2013-12-20 Utilisation de composes de diaminophenothiazinium en tant qu'agents de prevention, reduction ou suppression d'une radiotoxicite

Country Status (1)

Country Link
FR (1) FR3015481B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO81783A3 (fr) * 1982-06-16 1984-07-17 Intreprinderea De Medicamente "Biofarm",Ro Medicament pour le traitement de la maladie neoplastique
FR2810318B1 (fr) * 2000-06-15 2005-09-23 Laurent Galey Derives de diamano-phenothiazine
DK3121169T3 (da) * 2006-07-11 2022-02-28 Wista Lab Ltd Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser
KR20130092658A (ko) * 2012-02-12 2013-08-21 오은영 체내 유해물질의 해독을 위한 유효성분이 함유된 기능성차조성물과 기능성차

Also Published As

Publication number Publication date
FR3015481A1 (fr) 2015-06-26

Similar Documents

Publication Publication Date Title
MA41140A (fr) Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
EP2890691A4 (fr) Dérivés de benzimidazole en tant qu'inhibiteurs d'itk
EP2800602A4 (fr) Dispositifs de protection intégrée pour l'embolisation
EP2875826A4 (fr) Composition pour la prévention ou le traitement d'une sepsie
EP3386981A4 (fr) Hétérocycles utiles en tant qu'agents anticancereux
EP2820951A4 (fr) Composition d'agent bactéricide
EP2855324A4 (fr) Agencement de sécurité d'un ascenseur
EP2908825A4 (fr) Composés de dioxyde de thiadiazine substitués tricycliques en tant qu'inhibiteurs de bace, compositions et leur utilisation
MA53108A (fr) Utilisation de prg4 comme agent anti-inflammatoire
MA46981A (fr) Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine
EP2863913A4 (fr) Analogues d'imidazolyle en tant qu'inhibiteurs de syk
PL3065732T3 (pl) Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemii
FR2988609B1 (fr) Formulation pour l'hormonotherapie
EP2979211A4 (fr) Protection d'application logicielle
EP2964039A4 (fr) Équipement de protection individuelle pour cbrn ou autre protection
EP2928888A4 (fr) Pyridopyrazines substituées utilisées en tant qu'inhibiteurs de syk
EP2968698A4 (fr) Composés et compositions pour libération de médicament
EP2956394A4 (fr) Circuit de sécurité d'ascenseur
EP3322451A4 (fr) Réduction ou prévention électrochimique d'infections
EP2545899A4 (fr) Composition pour la prévention de candidoses
EP2953470A4 (fr) Purines 2,6,7 substituées utilisées en tant qu'inhibiteurs de hdm2
PL3021840T3 (pl) Kompozycje do zapobiegania reakcji alergicznej
EP2815760A4 (fr) Agent pour prévenir ou améliorer un dysfonctionnement de l'endothélium vasculaire
FR2992861B1 (fr) Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
ZA201700518B (en) Use of active compound compositions

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

CA Change of address

Effective date: 20151228

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20190906